Ground Glass Opacity and Adjuvant Chemotherapy in Pathological Stage IB–IIA Lung Adenocarcinoma

BACKGROUND: The prognostic value of ground glass opacity (GGO) in stage IA non-small cell lung cancer (NSCLC) has been widely recognized. However, studies investigating its value in the related stage IB–IIA lung adenocarcinoma (LUAD) remains lacking. The impact of adjuvant chemotherapy (ACT) on path...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Wenyu, Gong, Li, Zheng, Yuzhen, Yan, Qihang, Lai, Renchun, Liang, Dachuan, Wong, Wingshing, Dai, Shuqin, Wang, Junye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990754/
https://www.ncbi.nlm.nih.gov/pubmed/35402251
http://dx.doi.org/10.3389/fonc.2022.851276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990754/
https://www.ncbi.nlm.nih.gov/pubmed/35402251
http://dx.doi.org/10.3389/fonc.2022.851276

Ejemplares similares